When adverse health events occur as the result of a medication or a medical device, the manufacturers can face civil litigation over the harm caused by their products. The beginning of this kind of litigation is sometimes called a bellwether trial. In bellwether trials, a judge is presented with enough information to determine if groups of cases should be settled. If it is determined that they should be settled, a dollar amount for the settlement is usually recommended.
Bellwether trials for the drug Granuflo were set to begin in January of this year. The first bellwether trial was scheduled to begin under Judge Douglas P. Woodlock in the District of Massachusetts. Some 1,800 cases have been consolidated. A second bellwether trial was also set to begin in February.
Fresenius Medical Care, Inc is facing lawsuits alleging that the company was aware of the danger presented by their products yet failed to adequately inform the public of these dangers. Further allegations state that they did not train medical personnel properly on the proper use of their products. They also failed to disclose potential dangers to medical personnel.
Granuflo is a dialysate used in kidney dialysis centers to treat kidney dysfunction and failure. The lawsuit includes patients who suffered adverse health events and even death after using Granuflo during hemodialysis.
The potential injuries and complications from using Granuflo are dire, indeed. They range from stroke, heart attack, cardiopulmonary arrest, and even death.
Fresenius Medical Care continues to contest liability in the cases against them. They are contesting causation and liability, which makes the litigation against the company very complex.
If you have suffered complications or injury resulting from the use of Granuflo during hemodialysis, you may be entitled to compensation. Contact the law office of John Foy & Associates today. The “Strong Arm” attorneys will work to get you the compensation you deserve. Contact us today.